Gregory Auffenberg
Urology · Saint Louis, MONPI 1396977328
Payments from drug & device makers
Across 273 payments — averaging $1714.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$338K
- Sumitomo Pharma America, Inc.$115K
- Dendreon Pharmaceuticals LLC$12K
- Urogen Pharma, Inc.$603
- Accord Healthcare, Inc.$364
- AbbVie$296
- plus $2K from 33 others
Across 1 payment — averaging $11,700 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dendreon Pharmaceuticals LLC$12K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 42 | $338,004 |
| Sumitomo Pharma America, Inc. | 73 | $114,675 |
| Dendreon Pharmaceuticals LLC | 12 | $12,000 |
| Urogen Pharma, Inc. | 22 | $603 |
| Accord Healthcare, Inc. | 7 | $364 |
| AbbVie | 19 | $296 |
| Merck | 12 | $224 |
| Boston Scientific | 2 | $223 |
| Pfizer | 8 | $148 |
| Olympus America Inc. | 2 | $145 |
| Johnson & Johnson | 8 | $143 |
| Novartis | 6 | $121 |
| Progenics Pharmaceuticals, Inc. | 5 | $118 |
| Bayer | 6 | $111 |
| Ferring Pharmaceuticals Inc. | 3 | $84 |
| Sun Pharmaceutical Industries Inc. | 4 | $83 |
| Myovant Sciences Inc. | 4 | $81 |
| AstraZeneca | 4 | $71 |
| Blue Earth Diagnostics | 3 | $56 |
| Astellas Pharma US Inc | 4 | $55 |
| Myriad Genetic Laboratories, Inc. | 3 | $54 |
| Verity Pharmaceuticals Inc. | 3 | $52 |
| Agiliti Health, Inc. | 1 | $48 |
| Urovant Sciences Inc | 3 | $43 |
| Teleflex LLC | 2 | $38 |
| Procept Biorobotics Corporation | 1 | $35 |
| Baxter Healthcare | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Endo USA, Inc. | 1 | $25 |
| Immunitybio, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Pharmaand GmbH | 2 | $17 |
| Calyxo, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Telix Pharmaceuticals | 1 | $14 |
| Amgen | 1 | $13 |
| Coloplast | 1 | $12 |
How this compares
$468,122 in reported general payments places this provider in the 95th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Saint Louis
- Travis BullockSaint Louis$751K
- Michael JohnsonSaint Louis$471K
- Gerald AndrioleSaint Louis$308K
- Hing LaiSaint Louis$173K
- Gautum AgarwalSaint Louis$111K
- Gurdarshan SandhuSaint Louis$101K
- Gregory McLennanSaint Louis$89K
- Gregory MurphySaint Louis$65K
- Charles JonesSaint Louis$55K
- Zachary HamiltonSaint Louis$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.